Journey Medical Statistics
Total Valuation
DERM has a market cap or net worth of $105.29 million. The enterprise value is $103.90 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, after market close.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
DERM has 20.73 million shares outstanding. The number of shares has increased by 9.94% in one year.
| Current Share Class | 14.73M |
| Shares Outstanding | 20.73M |
| Shares Change (YoY) | +9.94% |
| Shares Change (QoQ) | +2.72% |
| Owned by Insiders (%) | 5.33% |
| Owned by Institutions (%) | 11.45% |
| Float | 10.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.74 |
| Forward PS | 3.55 |
| PB Ratio | 9.64 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.80 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.38, with a Debt / Equity ratio of 1.93.
| Current Ratio | 1.38 |
| Quick Ratio | 0.99 |
| Debt / Equity | 1.93 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.52 |
Financial Efficiency
Return on equity (ROE) is -129.58% and return on invested capital (ROIC) is -42.89%.
| Return on Equity (ROE) | -129.58% |
| Return on Assets (ROA) | -17.33% |
| Return on Capital (ROIC) | -42.89% |
| Revenue Per Employee | $1.41M |
| Profits Per Employee | -$447,220 |
| Employee Count | 41 |
| Asset Turnover | 0.89 |
| Inventory Turnover | 2.16 |
Taxes
In the past 12 months, DERM has paid $126,000 in taxes.
| Income Tax | 126,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.96% in the last 52 weeks. The beta is 0.92, so DERM's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | +27.96% |
| 50-Day Moving Average | 5.61 |
| 200-Day Moving Average | 4.70 |
| Relative Strength Index (RSI) | 40.00 |
| Average Volume (20 Days) | 159,761 |
Short Selling Information
The latest short interest is 60,749, so 0.29% of the outstanding shares have been sold short.
| Short Interest | 60,749 |
| Short Previous Month | 76,691 |
| Short % of Shares Out | 0.29% |
| Short % of Float | 0.59% |
| Short Ratio (days to cover) | 0.71 |
Income Statement
In the last 12 months, DERM had revenue of $57.77 million and -$18.34 million in losses. Loss per share was -$0.93.
| Revenue | 57.77M |
| Gross Profit | 33.11M |
| Operating Income | -18.02M |
| Pretax Income | -3.94M |
| Net Income | -18.34M |
| EBITDA | -14.76M |
| EBIT | -18.02M |
| Loss Per Share | -$0.93 |
Full Income StatementBalance Sheet
The company has $22.46 million in cash and $21.07 million in debt, giving a net cash position of $1.39 million or $0.07 per share.
| Cash & Cash Equivalents | 22.46M |
| Total Debt | 21.07M |
| Net Cash | 1.39M |
| Net Cash Per Share | $0.07 |
| Equity (Book Value) | 10.93M |
| Book Value Per Share | 0.53 |
| Working Capital | 12.83M |
Full Balance SheetCash Flow
| Operating Cash Flow | -27.87M |
| Capital Expenditures | n/a |
| Free Cash Flow | -27.87M |
| FCF Per Share | -$1.34 |
Full Cash Flow StatementMargins
Gross margin is 57.32%, with operating and profit margins of -31.18% and -31.74%.
| Gross Margin | 57.32% |
| Operating Margin | -31.18% |
| Pretax Margin | -31.52% |
| Profit Margin | -31.74% |
| EBITDA Margin | -25.54% |
| EBIT Margin | -31.18% |
| FCF Margin | 1.47% |